Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Cytos Biotechnology AG
Age
18–65
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Patients with untreated mild-to-moderate essential hypertension, clinically diagnosed according to the World Health Organization criteria (systolic blood pressure =140-179 mm Hg and/or diastolic blood pressure =90-109 mm Hg on 3 consecutive occasions; standardized after 5 minutes in sitting position)
Patients with newly diagnosed essential hypertension or previously treated patients from whom antihypertensive therapy can be safely withdrawn for the duration of the study.
18 to 65 years of age, males and non-reproductive females (surgically sterilized or post-menopausal)
Written informed consent
Patient is willing and able to comply with all trial requirements
You may not be if
Secondary hypertension
Severe essential hypertension
Current pharmacological treatment that could affect blood pressure
